Researchers dig into patient histories to uncover clues about macrophage activation syndrome

NCT ID NCT06992505

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study reviewed the medical charts of 32 people with Still's disease who developed a serious complication called macrophage activation syndrome (MAS). The goal was to learn more about their symptoms, how long it took for lab values to return to normal, and what treatments were used. No new drug or intervention was tested; instead, researchers gathered information to better understand the condition and its management.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MACROPHAGE ACTIVATION SYNDROME (MAS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico

    Milan, 20122, Italy

  • Ospedale Pediatrico Bambin Gesù

    Rome, 00165, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.